CorMedix (CRMD) Just Tripled Its Profits, But Guidance Barely Budged
On August 13, CorMedix (NASDAQ:CRMD) reported second quarter revenue of $101.9 million, more than double what it posted a year earlier, alongside net income of $26 million and adjusted EBITDA of $58.7...








